• / Free eNewsletters & Magazine
  • / My Account
Home>News Highlights: Top Company News of the Day

News Highlights: Top Company News of the Day

News Highlights: Top Company News of the Day


 Equifax Board Considers Clawing Back Executives' Compensation 

Equifax could announce in coming days that it will claw back compensation from some top executives over its massive data breach.

 VW Takes New $2.9 Billion Hit From Diesel Scandal 

Volkswagen warned that its third-quarter operating result would take a hit of around $2.94 billion as the company continues to grapple with the fallout of the diesel emissions scandal.

 Fed Fines HSBC $175 Million for Foreign Exchange Trading Practices 

The Fed said a former HSBC executive currently on trial misused confidential information while carrying out foreign exchange trades for a client, as it fined the bank $175 million for more broadly failing to supervise its foreign-exchange trading business.

 Bank of America Shuffles Wealth Management Ranks 

Bank of America Corp. is shuffling the top ranks within its wealth-management unit, a move that comes as that business takes on increasing importance across Wall Street.

 Hudson River Trading Explores Deal for Sun Trading 

Hudson River Trading, one of the largest U.S. high-speed traders, is exploring a deal to buy rival Sun Trading, people familiar with the situation said, as the once-lucrative business of high-frequency trading is pressured by low volatility and rising costs.

 ISS Backs Peltz's Trian in Procter & Gamble Board Fight 

Institutional Shareholder Services, the largest proxy-advisory firm, is recommending Procter & Gamble shareholders put activist investor Nelson Peltz on the board over the company's protests.

 Uber CEO to Meet With London Transport Regulator About Operating License 

Uber Technologies Inc.'s new chief executive plans to meet with London's top transport regulator to plead for a reversal of last week's decision to strip the ride-hailing company of its operating license.

 Merck Abandons New Hepatitis C Drugs 

Merck & Co. is halting development of new hepatitis C treatments after reviewing their effectiveness and determining an abundance of treatments were already available.

©2017 Morningstar Advisor. All right reserved.